Hyperfine, Inc. (HYPR) vs MediciNova, Inc. (MNOV)
A side-by-side comparison of Hyperfine, Inc. and MediciNova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HYPR
Hyperfine, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
MNOV
MediciNova, Inc.
$1.68HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
Total return — HYPR vs MNOV
growth of $100 · dividends reinvested · last 6yHYPR -91.2% (-33.3%/yr)MNOV -71.0% (-18.6%/yr)MNOV compounded faster over this window
HYPR MNOV
HYPR vs MNOV: by the numbers
- •MNOV is the larger company ($83M vs $76M market cap).
- •Both run net losses; HYPR's is the smaller (-210.75% vs -1168.20% net margin).
- •HYPR grew revenue faster over the past five years (77.73% vs -25.46% CAGR).
Metrics side by side
Valuation
| Metric | HYPR | MNOV |
|---|---|---|
| P/S ratio | 4.60 | 89.84 |
| P/B ratio | 2.07 | 2.22 |
Profitability
| Metric | HYPR | MNOV |
|---|---|---|
| Gross margin | 51.41% | 7.58% |
| Operating margin | -273.43% | -3242.47% |
| Net margin | -210.75% | -1168.20% |
| ROE | -94.81% | -28.85% |
| ROIC | -62.98% | -31.62% |
Growth (annualized)
| Metric | HYPR | MNOV |
|---|---|---|
| Revenue CAGR (5Y) | 77.73% | -25.46% |
| Total return CAGR (5Y) | -38.34% | -13.62% |
Frequently asked
- Which has grown faster, HYPR or MNOV?
- Over the past five years, HYPR grew revenue faster — HYPR at a 77.73% CAGR versus MNOV at -25.46%.
- How have HYPR and MNOV total returns compared?
- Over the past 5 years, HYPR delivered -38.34% and MNOV delivered -13.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Hyperfine ROEMediciNova ROEHyperfine operating marginMediciNova operating marginHyperfine revenue growthMediciNova revenue growthHyperfine free cash flowMediciNova free cash flow
Hyperfine & MediciNova appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.